Saad is Managing Director at Yorkville Advisors. As the head of healthcare investments, he has led financing transactions for a variety of life science companies focused on biotechnology, molecular diagnostics, surgical instruments, and medical devices in the US and in Europe.
He also serves as a member of the firm’s investment committee. Prior to joining Yorkville Advisors Global, Saad worked at Keyence, where he held various management roles within the engineering and marketing groups. He is a member of the board of directors of Sweden-based Cyxone AB, a company focused on developing novel drugs for autoimmune and other diseases. Saad holds a B.Sc. in Electrical Engineering from Rutgers University and an MBA from Rutgers Business School.
